Acumen Pharmaceuticals, Inc. (ABOS) earnings
ABOS earnings moved a median of -1.51% by the close. Quarterly and annual ABOS reports and results, each read against the price at its own news timestamp. Back to the ABOS overview →
27 measured ABOS earnings events.
Where these ABOS earnings landedvs 25 measured ABOS earnings reactions
| Middle 50% of ABOS earnings reactions | -6.67% to +2.00% |
|---|---|
| Median reaction (to close) | -1.51% |
| Measured reactions | 25 |
Point-in-time · zero look-ahead
Half of the 25 ABOS earnings events with a measured close landed between -6.67% and +2.00%; 44% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights | Press release | +0.45% | +4.15% | |
| Form 10-Q Acumen Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +2.00% | |
| Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights | Press release | -2.33% | -3.88% | |
| Form 10-Q Acumen Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +2.02% | +0.40% | |
| Form 10-K Acumen Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -8.87% | |
| Acumen Pharmaceuticals Reports Third Quarter 2025 Financial Results and Business Highlights | Press release | -3.03% | -1.51% | |
| Form 10-Q Acumen Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -0.53% | — | |
| Acumen Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 12, 2025 | Press release | +0.00% | -5.00% | |
| Acumen Pharmaceuticals Reports Second Quarter 2025 Financial Results and Business Highlights | Press release | -0.02% | — | |
| Form 10-Q Acumen Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -1.54% | -2.31% | |
| Acumen Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 12, 2025 | Press release | +2.46% | +2.94% | |
| Acumen Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Highlights | Press release | -3.81% | +0.00% | |
| Form 10-Q Acumen Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -1.43% | -6.67% | |
| Acumen Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025 | Press release | +0.00% | +0.64% | |
| Form 10-K Acumen Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.40% | -4.03% | |
| Acumen Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Highlights | Press release | -3.28% | -16.41% | |
| Form 10-Q Acumen Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -0.73% | -7.33% | |
| Acumen Pharmaceuticals to Report Third Quarter Results on Nov. 12, 2024 | Press release | -2.15% | +6.95% | |
| Acumen Pharmaceuticals Reports Second Quarter 2024 Financial Results and Business Highlights | Press release | +2.40% | +10.80% | |
| Form 10-Q Acumen Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -1.08% | -9.53% | |
| Acumen Pharmaceuticals to Report Second Quarter Results on August 13, 2024 | Press release | +0.00% | -8.90% | |
| Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights | Press release | -0.28% | +2.79% | |
| Form 10-Q Acumen Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +1.90% | +2.98% | |
| Acumen Pharmaceuticals to Report First Quarter Results on May 14, 2024 | Press release | +2.38% | +1.19% | |
| Form 10-K Acumen Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +4.73% | -6.72% | |
| Acumen Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Highlights | Press release | -3.38% | -1.93% | |
| Form 10-Q Acumen Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -0.48% | +1.43% |
Keep exploring
More ABOS: analyst actions → · SEC filings → · ABOS overview →